| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.17M | - | |
| Dir | 2.83M | $456.78M | -669,596 | |
| CEO | 82.1K | $13.25M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2020 | Dadswell Charles82 | SVP &General Counsel | Sell | 1,686 | $268.02 | $451,881.72 | -14.3% | |
| Feb 18, 2020 | Ostadan Omead81 | SVP Mktg, Prod &Strat Plan | Sell | 1,800 | $298.87 | $537,958.85 | -4.3% | |
| Feb 5, 2020 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $300.24 | $187,650.00 | -5.6% | |
| Feb 3, 2020 | Samad Sam | SVP And CFO | Sell | 238 | $293.10 | $69,757.80 | -7.3% | |
| Feb 3, 2020 | Ragusa Robert P | SVP, Global Quality &Ops | Sell | 1,253 | $293.10 | $367,254.30 | -13.7% | |
| Jan 6, 2020 | Tousi Susan H81 | SVP Product Development | Sell | 200 | $325.00 | $65,000.00 | -0.5% | |
| Jan 2, 2020 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $330.99 | $206,867.50 | -2.7% | |
| Dec 10, 2019 | Ostadan Omead81 | SVP Mktg, Prod &Strat Plan | Sell | 1,200 | $326.01 | $391,212.00 | -13.3% | |
| Dec 6, 2019 | Tousi Susan H81 | SVP Product Development | Sell | 1,000 | $325.00 | $325,000.00 | -2.5% | |
| Dec 2, 2019 | Dadswell Charles82 | SVP &General Counsel | Sell | 655 | $320.33 | $209,816.15 | -15.5% |